Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Nutting, C M
and
Page, S R
1995.
Iatrogenic Cushing’s syndrome due to nasal betamethasone: a problem not to be sniffed at!.
Postgraduate Medical Journal,
Vol. 71,
Issue. 834,
p.
231.
Golding-Wood, David G.
Holmstrom, Mats
Darby, Yvonne
Scadding, Glenis K.
and
Lund, Valerie J.
1996.
The treatment of hyposmia with intranasal steroids.
The Journal of Laryngology & Otology,
Vol. 110,
Issue. 2,
p.
132.
Gazis, A. G.
Homer, J. J.
Henson, D. B.
Page, S. R.
and
Jones, N. S.
1999.
The effect of six weeks topical nasal betamethasone drops on the hypothalamo-pituitary-adrenal axis and bone turnover in patients with nasal polyposis.
Clinical Otolaryngology and Allied Sciences,
Vol. 24,
Issue. 6,
p.
495.
Penttilä
Poulsen
Hollingworth
and
Holmström
2000.
Dose‐related efficacy and tolerability of fluticasone propionate nasal drops 400 μg once daily and twice daily in the treatment of bilateral nasal polyposis: a placebo‐controlled randomized study in adult patients.
Clinical & Experimental Allergy,
Vol. 30,
Issue. 1,
p.
94.
Bong, J.L.
Connell, J.M.C.
and
Lever, R.
2000.
Intranasal betamethasone induced acne and adrenal suppression.
British Journal of Dermatology,
Vol. 142,
Issue. 3,
p.
579.
Keith, P.
Nieminen, J.
Hollingworth, K.
and
Dolovich, J.
2000.
Efficacy and tolerability of fluticasone propionate nasal drops 400 μg once daily compared with placebo for the treatment of bilateral polyposis in adults.
Clinical & Experimental Allergy,
Vol. 30,
Issue. 10,
p.
1460.
Caldas, Dayse
and
Schrank, Yolanda
2001.
Síndrome de Cushing por uso abusivo de descongestionante nasal contendo dexametasona: Relato de caso.
Revista Brasileira de Otorrinolaringologia,
Vol. 67,
Issue. 6,
p.
868.
Lima, Josivan G.
Nóbrega, Lúcia H.C.
Nóbrega, Maria L.C.
Rodrigues Jr., Anilton B.
and
Pereira, Alane F.F.
2002.
Supressão Hipotálamo-Hipófise-Adrenal e Risco de Insuficiência Adrenal Secundária Devido ao Uso de Dexametasona Nasal.
Arquivos Brasileiros de Endocrinologia & Metabologia,
Vol. 46,
Issue. 2,
p.
193.
Sizonenko, P.C.
2002.
Effects of Inhaled or Nasal Glucocorticoids on Adrenal Function and Growth.
Journal of Pediatric Endocrinology and Metabolism,
Vol. 15,
Issue. 1,
Tuncer, Sema
Barişkaner, Hülagü
Yosunkaya, Alper
Reisli, Ruhiye
and
Ökesli, Selmin
2004.
Systemic effects of epidural betamethasone injection.
The Pain Clinic,
Vol. 16,
Issue. 3,
p.
311.
Shetty, Sandeep
Vishwanathan, Harishnath
and
Carrie, Sean
2007.
The management of olfactory disorders.
British Journal of Hospital Medicine,
Vol. 68,
Issue. 5,
p.
241.
Snidvongs, Kornkiat
Pratt, Eleanor
Chin, David
Sacks, Raymond
Earls, Peter
and
Harvey, Richard J.
2012.
Corticosteroid nasal irrigations after endoscopic sinus surgery in the management of chronic rhinosinusitis.
International Forum of Allergy & Rhinology,
Vol. 2,
Issue. 5,
p.
415.
Sandhu, S S
Smith, J M
Doherty, M
James, A
and
Figueiredo, F C
2012.
Do topical ophthalmic corticosteroids suppress the hypothalmic-pituitary-adrenal axis in post-penetrating keratoplasty patients?.
Eye,
Vol. 26,
Issue. 5,
p.
699.
Joshi, Rohan R.
and
Maresh, Alison
2018.
Iatrogenic Cushing's syndrome and adrenal insufficiency in infants on intranasal dexamethasone drops for nasal obstruction – Case series and literature review.
International Journal of Pediatric Otorhinolaryngology,
Vol. 105,
Issue. ,
p.
123.
Donaldson, Angela M.
Choby, Garret
Kim, Daniel H.
Marks, Lisa A.
and
Lal, Devyani
2020.
Intranasal Corticosteroid Therapy: Systematic Review and Meta‐analysis of Reported Safety and Adverse Effects in Adults.
Otolaryngology–Head and Neck Surgery,
Vol. 163,
Issue. 6,
p.
1097.
Kothiwala, Mamta
Samdani, Sunil
Grover, Mohnish
and
Gurjar, Vishram
2022.
Efficacy of Topical High Volume Budesonide Nasal Irrigation in Post FESS Patients of Chronic Rhinosinusitis With or Without Nasal Polyposis.
Indian Journal of Otolaryngology and Head & Neck Surgery,
Vol. 74,
Issue. S2,
p.
1399.
Yoo, Shin Hyuk
Kim, Hae-Won
and
Lee, Jun Hee
2022.
Restoration of olfactory dysfunctions by nanomaterials and stem cells-based therapies: Current status and future perspectives.
Journal of Tissue Engineering,
Vol. 13,
Issue. ,
Schmidt, Diana C.
Kessel, Line
Bach‐Holm, Daniella
Main, Katharina M.
Larsen, Dorte A.
and
Bangsgaard, Regitze
2023.
Prevalence and risk factors for hypothalamus–pituitary–adrenal axis suppression in infants receiving glucocorticoid eye drops after ocular surgery.
Acta Ophthalmologica,
Vol. 101,
Issue. 2,
p.
229.
Yu, Pengju
Chen, Weiguan
Jiang, Ling
Jia, Yufeng
Xu, Xiaoyan
Shen, Weiye
Jin, Ni
and
Du, Hongjie
2024.
Olfactory dysfunction and the role of stem cells in the regeneration of olfactory neurons.
Heliyon,
Vol. 10,
Issue. 9,
p.
e29948.